Skip header and navigation
COVID-19 Rapid Evidence Reviews
  Refine Search

21 records – page 1 of 3.

Date Research Question / Title Unique ID Research Team
November 30, 2021 What are the risks associated with repeated exposure to Ethylene Oxide from ongoing use of the Abbott Panbio AG COVID-19 Nasal swabs? EOC211126 RR Table EOC
November 30, 2021 What are the risks associated with repeated exposure to Ethylene Oxide from ongoing use of the Abbott Panbio AG COVID-19 Nasal swabs? EOC211126 RR EOC
November 26, 2021 What are the risks associated with repeated exposure to Ethylene Oxide from ongoing use of the Abbott Panbio AG COVID-19 Nasal swabs? EOC211126 ESR EOC
July 16, 2021 What is known about safety/efficacy of global vaccines not approved in Canada? What are the impacts on international travel and vaccination policies? INF210701 ESR Infectious Disease
April 21, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 RR EOC
April 21, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 RR Table EOC
April 1, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 ESR EOC
March 12, 2021 What are the vaccination strategies for vulnerable populations? PH030401 RR Public Health
March 4, 2021 What are the vaccination strategies for vulnerable populations? PH030401-01 ESR Public Health
January 15, 2021 What evidence is available to inform vaccination planning in congregate living? EOC011102 RR EOC

21 records – page 1 of 3.